Department of Pharmacology Archives

Possible overeating antidote

Aug. 1, 2016—The 2C-subtype of the serotonin receptor (5HT2C), which binds the neurotransmitter serotonin, plays an important role in regulating food intake and metabolism.

May. 3, 2016—Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.

Honoring Blakely

Apr. 21, 2016—Meagan Quinlan, a Pharmacology graduate student in the laboratory of Randy Blakely, Ph.D., honored her mentor Tuesday during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall.

How strep grabs on to platelets

Apr. 20, 2016—New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.

Eye of a cytokine storm

Mar. 9, 2016—A new animal model can be used to “dissect” the inflammatory response to infection.

Schizophrenia expert Coyle set for next Flexner Discovery Lecture

Mar. 3, 2016—Joseph Coyle, M.D., an expert in the neurobiology of serious mental illness, will deliver the next Flexner Discovery Lecture on Thursday, March 10.

Grant bolsters rheumatoid arthritis research

Feb. 25, 2016—C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.

McLaughlin named a reviewing editor for neuroscience journal

Jan. 21, 2016—BethAnn McLaughlin, Ph.D., a neuroscientist at Vanderbilt University Medical Center, has been invited to serve as a reviewing editor for the Journal of Neuroscience, the flagship publication of the Society of Neuroscience, one of the world’s largest scientific societies.